Ghaskadbi S, Pavaskar S V, Vaidya V G
Mutat Res. 1987 Apr;187(4):219-22. doi: 10.1016/0165-1218(87)90039-5.
The mutagenic potential of diiodohydroxyquinoline (DIHQ), a common anti-amebic drug, was tested using the in vivo micronucleus test in Swiss mice following oral administration. It was found to be mutagenic in a dose-dependent manner. Using the same model system, the bio-antimutagenic effect of the sulfhydryl compound L-cysteine against DIHQ was established.
使用体内微核试验,对常用抗阿米巴药物二碘羟基喹啉(DIHQ)在口服给药后对瑞士小鼠的诱变潜力进行了测试。结果发现它具有剂量依赖性诱变作用。利用相同的模型系统,确定了巯基化合物L-半胱氨酸对DIHQ的生物抗诱变作用。